EEF1A1P2

Across TCGA pan-cancer cohorts, EEF1A1P2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated EEF1A1P2 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher EEF1A1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated EEF1A1P2 expression acts as an unfavorable survival marker, although some lineages such as THCA and KIRC show a favorable association.

STAD, THCA, and KIRC are the cancer types where EEF1A1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	III,IV	0.556	0.702	.013	28	view →
THCA	OS	Median	II,III,IV	0.952	0.789	.005	26	view →
KIRC	DFS	Median	II,III,IV	0.606	0.449	.005	25	view →
PAAD	DFS	Tertile	All	0.144	0.417	<.001	25	view →
SKCM	OS	Median	II,III,IV	0.895	0.784	.002	25	view →
LUSC	OS	Quartile	All	0.538	0.341	.005	25	view →
KIRP	DFS	Median	III,IV	0.529	0.833	.003	22	view →
DLBC	DFS	Median	All	0.550	1.000	.004	18	view →
COAD	OS	Median	All	0.912	0.824	.002	16	view →
UCS	DFS	Tertile	IV	0.996	0.540	.036	12	view →
ACC	OS	Tertile	II,III,IV	0.288	0.821	.006	11	view →
MESO	OS	Median	All	0.440	0.649	.001	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

EEF1A1P2–STAD (OS)

Open the STAD breakdown →